PleoPharma
PLEOPHARMA, INC.
PleoPharma pharmaceutical company homepage, management team, product offering, contact us.
pleopharma.com · Phoenixville, PA
Funding event
The round itself, as filedInferred stageSeed
Sold of offered$5.5M of $15.0M
Filed2026-08-10
Days since filing55
- Exemption claimed
- Rule 506(b)
- First-ever Form D
- No
- Date of first sale
- 2026-07-28
Investors
No investors named: Form D does not list them
Officers on the filing
Names and roles as filed; addresses are never stored- Ginger ConstantineExecutive Officer · Director
- Jay ConstantineExecutive Officer · Director
- Robert FinizioExecutive Officer · Director
- Paul BisaroDirector
- Tommy ThompsonDirector
- Sarah HassanDirector
- Brij SharmaDirector
- Kyle MowitzDirector
- Kyle TomlinDirector
- Poche ThomasExecutive Officer
- Daniel CartwrightExecutive Officer
- McInerney TimothyDirector
Health flags
Three flags, each with the raw inputs behind it · as of 2026-10-03UndersubscribedNot flagged36.7% sold2.2 months since first sale
Prior raiseNot flaggedPrior raise not known—
AmendedNot flaggedNo amendmentNo D/A on file
Open roles
On the employer's own careers page · checked 2026-09-240
Pre-posting windowNot enough dataShown once this sector and stage have 20 observed lags from filing to first posting.
No open roles foundWe read careers pages daily.
Also raised in Health & bio
Same sector, 28 days to 2026-10-04Altay TherapeuticsSeries A · $15.7M of $45.1M · San Carlos, CAQuietCarebilitySeries A · $8.8M of $8.8M · Richardson, TXQuiet
75 rounds in Health & bio in the 28 days to 2026-10-03, against 71 in the 28 days before.